Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
暂无分享,去创建一个
H. Döhner | M. Hallek | L. Klein-Hitpass | S. Stilgenbauer | J. Dürig | A. Hüttmann | U. Dührsen | L. Eisele | R. Scholtysik | R. Busch | P. Johansson | T. Seiler | M. Bergmann | M. Göbel | M. Möllmann | Maria Göbel
[1] C. Sephton,et al. Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration* , 2012, The Journal of Biological Chemistry.
[2] E. Lee,et al. Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort Study , 2012, PloS one.
[3] R. Petersen,et al. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin , 2012, Neurology.
[4] J. Greally,et al. Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia , 2012, PloS one.
[5] J. Molinuevo,et al. Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort. , 2012, Journal of Alzheimer's disease : JAD.
[6] Gang Li,et al. Progranulin overexpression predicts overall survival in patients with glioblastoma , 2012, Medical Oncology.
[7] D. Dréau,et al. Progranulin Stimulated by LPA Promotes the Migration of Aggressive Breast Cancer Cells , 2011, Cell communication & adhesion.
[8] L. Rimassa,et al. Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism , 2011, Gut.
[9] S. Sorbi,et al. Progranulin Genetic Screening in Frontotemporal Lobar Degeneration Patients From Central Italy , 2011, Cellular and Molecular Neurobiology.
[10] Xiao-hong Wang,et al. Clinicopathologic and prognostic implications of progranulin in breast carcinoma. , 2011, Chinese medical journal.
[11] Babykumari P. Chitramuthu,et al. Structure, Function, and Mechanism of Progranulin; the Brain and Beyond , 2011, Journal of Molecular Neuroscience.
[12] G. Serrero,et al. GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells , 2011, BMC Cancer.
[13] H. Ploegh,et al. Granulin is a soluble cofactor for toll-like receptor 9 signaling. , 2011, Immunity.
[14] A. Rosenwald,et al. CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. , 2011, Blood.
[15] S. Steinberg,et al. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. , 2011, Gynecologic oncology.
[16] R. Siebert,et al. Gene dosage effects in chronic lymphocytic leukemia. , 2010, Cancer genetics and cytogenetics.
[17] L. Klein-Hitpass,et al. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. , 2010, Leukemia research.
[18] Robert V Farese,et al. MicroRNA-29b Regulates the Expression Level of Human Progranulin, a Secreted Glycoprotein Implicated in Frontotemporal Dementia , 2010, PloS one.
[19] F. Arechavaleta-Velasco,et al. Expression of Progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in Benign and Malignant Ovarian Tumors and Activation of MAPK Signaling in Ovarian Cancer Cell Line , 2010, Cancer investigation.
[20] L. Klein-Hitpass,et al. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia , 2009, European journal of haematology.
[21] F. Lovat,et al. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. , 2009, The American journal of pathology.
[22] Emili Montserrat,et al. New prognostic markers in chronic lymphocytic leukemia. , 2008, Blood reviews.
[23] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[24] S. Cheung,et al. Granulin‐epithelin precursor as a therapeutic target for hepatocellular carcinoma , 2008, Hepatology.
[25] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[26] L. Klein-Hitpass,et al. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status , 2006, Leukemia.
[27] G. Marti,et al. ZAP‐70 in CLL: Towards standardization of a biomarker for patient management: History of clinical cytometry special issue , 2006, Cytometry. Part B, Clinical cytometry.
[28] L. Klein-Hitpass,et al. Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia , 2006, Leukemia & lymphoma.
[29] J. Hayashi,et al. PC Cell–Derived Growth Factor Confers Resistance to Dexamethasone and Promotes Tumorigenesis in Human Multiple Myeloma , 2006, Clinical Cancer Research.
[30] Muller Fabbri,et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.
[31] L. Klein-Hitpass,et al. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[32] J. Hayashi,et al. PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] T. Möröy,et al. Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. , 2003, Blood.
[34] F. Marshall,et al. Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium. , 2001, Anticancer research.
[35] A. Bateman,et al. Cellular Localization of Gene Expression for Progranulin , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.